RxSight, Inc., an Aliso Viejo, CA-based medical technology company that has commercialized FDA-approved adjustable intraocular lens that is customized after cataract surgery, closed a $60m senior secured term loan with Oxford Finance.
The funds will be used for general working capital, including sales and marketing, and research and development.
RxSight has developed FDA-approved adjustable intraocular lens that is customized after cataract surgery. The RxSight® Light Adjustable Lens™ allows patients to customize their vision after cataract surgery until it meets their personal desires and lifestyle requirements. This optimization is performed by an eye doctor after lens implantation through a series of office-based light treatment procedures that take only a few minutes each.
Today, approximately 100 US surgeons are using the Light Adjustable Lens.
FinSMEs
02/12/2020